Manufacturer
GLAXOSMITHKLINE LLC(UNITED STATES)
Registraction Number
MAL14115018ARZ
Pre-Dispensed Content:
Each inhalation delivers 184 micrograms of fluticasone furoate and 22 micrograms of vilanterol. This corresponds to a pre-dispensed dose of 200 micrograms of fluticasone furoate and 25 micrograms of vilanterol.
Indication:
Relvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older. It is used when a combination product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate1. It is also used for the symptomatic treatment of COPD in adults with a history of exacerbations despite regular bronchodilator therapy.
Instructions: